Kim Se Hyung, Choi Byung Ihn, Lee Jae Young, Kim Soo Jin, So Young Ho, Eun Hyo Won, Lee Jeong Min, Han Joon Koo
Department of Radiology and Institute of Radiation Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Intervirology. 2008;51 Suppl 1:52-60. doi: 10.1159/000122598. Epub 2008 Jun 10.
Liver transplantation has been considered to be the only causal treatment for liver cirrhosis patients with hepatocellular carcinoma (HCC) due to its theoretical advantage of eliminating both the tumor and liver disease. However, because of the shortage of donor organs, it is strongly recommended that liver transplantations should be performed on cirrhotic patients with HCCs only when the patients meet the predetermined criteria in terms of number and extent of HCCs. Imaging is thus decisive in the patient inclusion or exclusion from transplantation lists. The imaging techniques used are CT, MRI and ultrasonography. The latter has been proven to be ineffective for HCC surveillance in transplant recipients because of its heavy operator dependence and unreliable detection of small and intermediately sized HCCs. The purpose of this article, then, is to systematically review the diagnostic performances of single-/multidetector row CT, dynamic gadolinium-enhanced MRI, superparamagnetic iron oxide (SPIO)-enhanced MRI and double-contrast MRI using both gadolinium and SPIO for the detection of HCCs with special emphasis on liver transplantation.
由于肝移植在理论上具有消除肿瘤和肝脏疾病的优势,它一直被视为肝硬化合并肝细胞癌(HCC)患者的唯一根治性治疗方法。然而,由于供体器官短缺,强烈建议仅在肝硬化合并HCC患者符合HCC数量和范围的预定标准时才进行肝移植。因此,影像学检查对于决定患者是否能列入移植名单至关重要。所使用的影像学技术包括CT、MRI和超声检查。由于超声检查严重依赖操作人员且对小和中等大小的HCC检测不可靠,已证明其对移植受者的HCC监测无效。因此,本文的目的是系统评价单排/多排CT、动态钆增强MRI、超顺磁性氧化铁(SPIO)增强MRI以及同时使用钆和SPIO的双对比MRI对HCC的诊断性能,特别强调与肝移植的关系。